Citation: | LIU Haoyu, PENG Wenjia, MI Jing, JIA Xianjie, ZHANG Yuyuan. APC analysis of the global disease burden of Parkinson's disease from 1990 to 2019[J]. Chinese Journal of General Practice, 2024, 22(1): 154-157. doi: 10.16766/j.cnki.issn.1674-4152.003353 |
[1] |
赵亚军, 田久鹏, 王德强, 等. 上海市社区全科医生对帕金森病的诊断认知及影响因素分析[J]. 中华全科医学, 2022, 20(5): 808-811. doi: 10.16766/j.cnki.issn.1674-4152.002460
ZHAO Y J, TIAN J P, WANG D Q, et al. Diagnosis cognition and influencing factors of Parkinson disease among community general practitioners in Shanghai[J]. Chinese Journal of General Practice, 2022, 20(5): 808-811. doi: 10.16766/j.cnki.issn.1674-4152.002460
|
[2] |
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(5): 459-480. doi: 10.1016/S1474-4422(18)30499-X
|
[3] |
ELSWORTH J D. Parkinson's disease treatment: past, present, and future[J]. J Neural Transm (Vienna), 2020, 127(5): 785-791. doi: 10.1007/s00702-020-02167-1
|
[4] |
丁贤彬, 吕晓燕, 毛德强, 等. 2010—2017年重庆市宫颈癌疾病负担变化趋势分析[J]. 中国肿瘤, 2019, 28(9): 657-662. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201909005.htm
DING X B, LV X Y, MAO D Q, et al. Trend Analysis of Disease Burden of Cervical Cancer from 2010 to 2017 in Chongqing[J]. China Cancer, 2019, 28(9): 657-662. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201909005.htm
|
[5] |
罗丽莎, 栾航航, 朱聪, 等. 1990—2019年中国、日本与韩国的良性前列腺增生疾病负担比较[J]. 现代泌尿外科杂志, 2023, 28(6): 506-512. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202306010.htm
LUO L S, LUAN H H, ZHU C, et al. Disease burden of benign prostatic hyperplasia in China, Japan and South Korea from 1990 to 2019: a comparative study[J]. Journal of Modern Urology, 2023, 28(6): 506-512. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202306010.htm
|
[6] |
GBD. Global health data exchange[EB]. (2019-08-11)[2023-05-20].
|
[7] |
曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计, 2019, 36(5): 787-791. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201905044.htm
ZENG S Q. Joinpoint regression model and its application in the analysis of epidemic trend of infectious diseases[J]. Chinese Journal of Health Statistic, 2019, 36(5): 787-791. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201905044.htm
|
[8] |
RAJAN S, KAAS B. Parkinson's disease: risk factor modification and prevention[J]. Semin Neurol, 2022, 42(5): 626-638. doi: 10.1055/s-0042-1758780
|
[9] |
CERRI S, MUS L, BLANDINI F. Parkinson's disease in women and men: what's the difference?[J]. J Parkinsons Dis, 2019, 9(3): 501-515.
|
[10] |
BRAKEDAL B, TOKER L, HAUGARVOLL K, et al. A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population[J]. NPJ Parkinsons Dis, 2022, 8(1): 19.
|
[11] |
BOULOS C, YAGHI N, EL HAYECK R, et al. Nutritional risk factors, microbiota and Parkinson's disease: what is the current evidence?[J]. Nutrients, 2019, 11(8): 1896. doi: 10.3390/nu11081896
|
[12] |
张硕, 高健, 姜立刚. 帕金森病患病率及相关因素的流行病学研究现状[J]. 吉林医药学院学报, 2021, 42(6): 437-439. https://www.cnki.com.cn/Article/CJFDTOTAL-JLDS202106016.htm
ZHANG S, GAO J, JIANG L G. Current status of epidemiological studies on the prevalence and related factors of Parkinson's disease[J]. Journal of Jilin Medical College, 2021, 42(6): 437-439. https://www.cnki.com.cn/Article/CJFDTOTAL-JLDS202106016.htm
|
[13] |
黄荣, 李晓晖, 陈文武. 帕金森病患者危险因素分析[J]. 罕少疾病杂志, 2022, 29(6): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-HSJB202206006.htm
HUANG R, LI X H, CHEN W W. Analysis of Risk Factors in Patients with Parkinson's Disease[J]. Journal of Rare and Uncommon Diseases, 2022, 29(6): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-HSJB202206006.htm
|
[14] |
周桃峰, 周志明. 帕金森病的诊断与治疗[J]. 中华全科医学, 2019, 17(12): 1982-1983. http://www.zhqkyx.net/article/id/70de6dad-4539-43a9-9096-481d8db02a44
ZHOU T F, ZHOU Z M. Diagnosis and treatment of Parkinson's disease[J]. Chinese Journal of General Practice, 2019, 17(12): 1982-1983. http://www.zhqkyx.net/article/id/70de6dad-4539-43a9-9096-481d8db02a44
|
[15] |
YASUHARA T. Neurobiology research in Parkinson's disease[J]. Int J Mol Sci, 2020, 21(3): 793.
|